Castle Biosciences, Inc. (CSTL)
33.08
-0.11
(-0.33%)
USD |
NASDAQ |
Oct 23, 16:00
33.18
+0.10
(+0.30%)
After-Hours: 20:00
Castle Biosciences Price to Book Value : 2.147 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.147 |
| October 22, 2026 | 2.154 |
| October 21, 2026 | 2.231 |
| October 20, 2026 | 2.152 |
| October 19, 2026 | 2.088 |
| October 16, 2026 | 2.074 |
| October 15, 2026 | 2.194 |
| October 14, 2026 | 2.149 |
| October 13, 2026 | 2.134 |
| October 12, 2026 | 2.126 |
| October 09, 2026 | 2.234 |
| October 08, 2026 | 2.188 |
| October 07, 2026 | 2.142 |
| October 06, 2026 | 2.165 |
| October 05, 2026 | 2.379 |
| October 02, 2026 | 2.308 |
| October 01, 2026 | 2.288 |
| September 30, 2026 | 2.306 |
| September 29, 2026 | 2.264 |
| September 28, 2026 | 2.332 |
| September 25, 2026 | 2.324 |
| September 24, 2026 | 2.284 |
| September 23, 2026 | 2.264 |
| September 22, 2026 | 2.262 |
| September 21, 2026 | 2.271 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.294 |
| September 17, 2026 | 2.387 |
| September 16, 2026 | 2.303 |
| September 15, 2026 | 2.304 |
| September 14, 2026 | 2.170 |
| September 11, 2026 | 2.098 |
| September 10, 2026 | 2.098 |
| September 09, 2026 | 2.097 |
| September 08, 2026 | 2.126 |
| September 04, 2026 | 2.136 |
| September 03, 2026 | 2.119 |
| September 02, 2026 | 2.169 |
| September 01, 2026 | 2.170 |
| August 31, 2026 | 2.144 |
| August 28, 2026 | 2.174 |
| August 27, 2026 | 2.224 |
| August 26, 2026 | 2.212 |
| August 25, 2026 | 2.272 |
| August 24, 2026 | 2.172 |
| August 21, 2026 | 2.220 |
| August 20, 2026 | 2.137 |
| August 19, 2026 | 2.098 |
| August 18, 2026 | 1.884 |
| August 17, 2026 | 1.944 |
| August 14, 2026 | 1.923 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| RadNet, Inc. | 5.047 |
| Lumexa Imaging Holdings, Inc. | 1.821 |
| Quest Diagnostics, Inc. | 3.486 |
| Labcorp Holdings, Inc. | 3.092 |
| OPKO Health, Inc. | 1.027 |
Price to Book Value Related Metrics
| PS Ratio | 2.747 |
| PEG Ratio | -0.6135 |
| Price | 33.08 |
| Earnings Yield | -1.97% |
| Market Cap | 1.009B |
| PEGY Ratio | -0.6135 |